Belperio, John A.

Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice

Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., & Deng, J. C. (2009) · Journal of Clinical Investigation

interferon and immune responsesChemokine receptors and signaling

Cited by 479

Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review

Belperio, J. A., Shaikh, F., Abtin, F. G., Fishbein, M. C., Weigt, S. S., Saggar, R., & Lynch, J. P. (2022) · JAMA

Sarcoidosis and Beryllium Toxicity ResearchInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 191

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials

Maher, T. M., Ford, P., Brown, K. K., Costabel, U., Cottin, V., Danoff, S. K., Groenveld, I., Helmer, E., Jenkins, R. G., Milner, J., et al. (2023) · JAMA

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 148

IL-12 attenuates bleomycin-induced pulmonary fibrosis

Keane, M. P., Belperio, J. A., Burdick, M. D., & Strieter, R. M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases

Cited by 146

Categorization of lung mesenchymal cells in development and fibrosis

Liu, X., Rowan, S. C., Liang, J., Yao, C., Huang, G., Deng, N., Xie, T., Wu, D., Wang, Y., Burman, A., et al. (2021) · iScience

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSingle-cell and spatial transcriptomics

Cited by 91

Lung transplant outcomes in systemic sclerosis with significant esophageal dysfunction. A comprehensive single-center experience

Miele, C. H., Schwab, K., Saggar, R., Duffy, E., Elashoff, D., Tseng, C.-H., Weigt, S., Charan, D., Abtin, F., Johannes, J., et al. (2016) · Annals of the American Thoracic Society

Transplantation: Methods and OutcomesSystemic Sclerosis and Related Diseases

Cited by 81

Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial

Cottin, V., Martinez, F. J., Jenkins, R. G., Belperio, J. A., Kitamura, H., Molina-Molina, M., Tschoepe, I., Coeck, C., Lievens, D., & Costabel, U. (2022) · Respiratory Research

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSystemic Sclerosis and Related Diseases

Cited by 53

Lung Transplantation and Coronary Artery Disease

Sherman, W., Rabkin, D. G., Ross, D., Saggar, R., Lynch, J. P., Belperio, J., Saggar, R., Hamilton, M., & Ardehali, A. (2011) · The Annals of Thoracic Surgery

Transplantation: Methods and OutcomesOrgan Transplantation Techniques and Outcomes

Cited by 40

Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort

Todd, J. L., Neely, M. L., Overton, R., Mulder, H., Roman, J., Lasky, J. A., de Andrade, J. A., Gulati, M., Huang, H., Leonard, T. B., et al. (2022) · Lung

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases

Cited by 14